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ScienceDirectThe increasing consumption of plant-based products for
health promotion or for disease treatment has generated
public health concerns, since herbs or plants are in direct
contact with soils and may easily be colonized by fungi. Many
studies have shown the contamination of plant-based
supplements and drugs with mycotoxigenic fungal species.
Aspergillus and Penicillium species have been reported as the
most frequent and dominant ones, with records of the
occurrence of many mycotoxigenic species. The presence of
different species raises the concern of multimycotoxin
occurrence, while the increased consumption of these
products increases exposure. This review aims to present
updated data on the natural occurrence of mycotoxigenic
fungi and their mycotoxins in plant-based supplements and
medicines.
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Introduction
Phytotherapy is a field of science that uses plants either to
treat diseases or as health-promoting agents [1]. These
plant drugs are crude preparations of dried plants or any
part thereof, such as leaf, stem, root, flower, or seed
[2,3]. Plant-based dietary supplements (concentrated
sources of vitamins, minerals, and other biologically
active substances) are mostly formulated as infusions,
oils, tablets and capsules containing dried ethanolic
extracts of active compounds, which are used for health
promotion or to aid drug treatments.
According to the World Health Organization [4], the use
of phytotherapy is popular and the primary source of
health care in countries with lower accessibility towww.sciencedirect.com conventional medicine — Africa and some developing
countries, but also in developed countries due to cultural
influence — as in some Asian countries [4] — or as com-
plementary therapy — being used by about 70% of the
Australians and one third of the Americans [5,6]. The
medicinal plants global market size is expanding and was
valued at USD 71.19 billion in 2016 by Hexa Research [7].
This growth may be attributed to the belief that these
products do not cause overdose toxicity and have fewer
side effects.
However, it is important to highlight that plant-based
products may also present toxicity and contamination
(chemical, biological, radiological, and so on), since herbs
and plants are in direct contact with soil, and common
practices employed for their production do not avoid
potential contamination. Plants and herbs can be contam-
inated with fungi either in the pre-harvest or in the post-
harvest and storage stages [8,9], which may produce
mycotoxins that remain in the product even after com-
plete destruction of the fungi.
Mycotoxins are secondary metabolites produced by dif-
ferent fungi, mainly by toxigenic species of the genus
Alternaria, Aspergillus, Fusarium and Penicillium. According
to Do et al. [10], aflatoxins (AFs), ochratoxin A (OTA),
fumonisins (FB), zearalenone (ZEN) and deoxynivalenol
(DON) are the most frequently detected in herbal med-
icines and can cause severe health problems like immu-
nosuppression, carcinogenesis, genotoxic, hepatotoxic
and nephrotoxic effects [11,12].
The present review addresses the occurrence of toxigenic
fungi and their mycotoxins in plant-based supplements
and medicines, to better understand the risk of multi-
mycotoxin exposure from the consumption of these
products.
Fungal occurrence in plant-based
supplements and medicines
Since the middle of the 20th century, researchers have
identified the presence of fungi in herbal drugs [13,14].
Hitokoto et al. [15] evaluated 49 powdered herbal drugs
for their mycobiota, being Aspergillus and Penicillium the
dominant ones. Aspergillus niger group was the most fre-
quently isolated and most widely distributed group
(24.6% of the isolates), mostly occurring in powdered
coptis (number of isolates of 3438/g), powdered scutel-
laria roots (2241/g), powdered Japanese peony roots
(1523/g), and powdered cininidium (1133/g).Current Opinion in Food Science 2019, 30:27–31
28 Food safetyA survey on the fungal contamination of sun dried herbal
drugs from Nigeria revealed a severe fungal contamina-
tion [16,17], where twenty-eight fungal species were
isolated, with A. niger, Aspergillus flavus, Fusarium verti-
cillioides, Trichoderma viride, Penicillium expansum and
Mucor fragilis being the dominant ones.
The mycobiota and mycotoxin contamination of herbal
drugs from Japan and India was also reported. Yamazaki
et al. [18] found fungal infection in 17 out of 50 samples in
Japan, and detected aflatoxin B1 (AFB1) and sterigma-
tocystin (STC). Aspergillus and Fusarium species (54 and
24%, respectively) were the most frequently isolated ones
from Indian drugs, and mycotoxins were detected in 43%
and 64% of the crude herbal drugs and of their finished
commercial products, respectively [19]. AFB1 was the
most frequently detected mycotoxin and was detected
above tolerance levels fixed by the World Health Orga-
nization-WHO.
Halt [20] analysed the level of toxigenic moulds in
62 samples of medicinal plants and 11 samples of herbal
tea. The dominant fungi detected were Aspergillus,
Penicillium, Mucor, Rhizopus, Absidia, Alternaria, Clados-
porium and Trichoderma species. A. flavus, a known
producer of aflatoxins, was present in 11 (18%) and
in 1 (9%) of the medicinal plants and herbal tea sam-
ples, respectively.
Medicinal plants (peppermint, chamomile flowers, tilio,
anise and caraway) from the Egyptian market also pre-
sented contamination by A. niger, Fusarium spp. and
Penicillium spp. which were detected with a frequency
of 77% in packed tilio and 56% in caraway samples [21]. A.
flavus was detected in all tested medicinal plants with the
exception of packed tilio, and the highest percentage of
infection was in peppermint (15.8%) followed by non-
packed tilio (15.4%), as well as non-packed caraway
(13.5%). Abou Donia [22] also identified Aspergillus,
Fusarium and Penicillium in Egyptian medicinal plants,
but aflatoxins were not detected.
In an evaluative study of the predominant mycobiota
contamination of 65 different medicinal plants from
Brazil, Bugno et al. [23] identified 10 fungal genera
and 55% of the samples exceeded the maximum fungal
count limit determined by the US Pharmacopoeia
(102 CFU/g). The genus Aspergillus was the most fre-
quent one (179 isolates) followed by Penicillium (44 iso-
lates), and these two genera were found in 90% and 40%
of the samples analysed, respectively. Isolated strains
included A. flavus, A. niger, Aspergillus ochraceus, Aspergil-
lus parasiticus, Penicillium citrinum and Penicillium
chrysogenum. Almost 22% of these isolates were able to
produce mycotoxins: 42.9% were aflatoxigenic strains,
22.4% were ochratoxigenic strains and 34.7% were citri-
nin-producing strains.Current Opinion in Food Science 2019, 30:27–31 Ahmad et al. [24] screened plants from Pakistan and
detected fungal contamination in 90% of tested samples,
of which 70% exceeded the permissible limits; being
opium poppy, liquorice root, and Indian rennet the most
contaminated medicinal plants. The predominant fungal
strains isolated belonged to Aspergillus (A. flavus, A. niger
and A. parasiticus) and Penicillium species, and 31% of the
47 isolates tested were found to be toxigenic. The authors
highlighted that these results could give rise to trade
barriers, since 12% of Pakistani flora is used in medicines
and more than 300 medicinal plants are traded all over the
world [25].
Fungi were isolated from all samples of Pu-erh tea (made
from the leaves and stems of the Camellia sinensis plant)
which contains small amounts of lovastatin, a well-
known medicine used for lowering cholesterol. A con-
centration of colony forming units of 10 to 2.6  106/g
was found, from 19 genera and 31 species. The most
prevalent species were Aspergillus acidus and Aspergillus
fumigatus [26].
Wu et al. [27] studied a previously isolated Alternaria
tenuissima strain from the stem of Tribullus terrestris L.,
a medicinal plant and a dietary supplement used to lose
weight all over the world, and found it to be a producer of
mycotoxins (altertoxins II and IV).
Chinese functional foods presented 124 fungal strains
distributed over four different genera [28], being Asper-
gillus and Penicillium strains the dominant ones, with an
incidence of 66% and 15%, respectively. Aspergillus sec-
tion Nigri (57%) was isolated more often, followed by
Aspergilus sections Flavi (50%) and Circumdati (21%), with
the most contaminated samples being Coix seeds. The
latter three Aspergillus sections are well known for their
mycotoxigenic potential.
Chen et al. [2] assessed internal and superficial fungal
contamination and multi-mycotoxin occurrence in
medicinal seeds used as food in China. The superficial
mycobiota on seed surfaces included 34 species (17 gen-
era). A. niger and Penicillium polonicum were predomi-
nant (12% and 15%, respectively). The internal fungal
incidence was also very high, with the isolation of
352 fungal strains, belonging to 12 genera and 27 spe-
cies. Chaetomium globosporum was the most commonly
identified fungus (23% of the internal fungal isolates),
followed by Microascus trigonosporus and Alternaria alter-
nata (12% and 9% of total internal fungal counts,
respectively). Total fungal counts ranged from
6.5  101 to 8.1  104/g on seed surfaces, being Aspergil-
lus, Penicillium, Mucor, and Fusarium the four most
predominant genera detected in association with all
medicinal seeds (exception for spider flower seed),
representing about 41%, 29%, 6% and 5% of the iso-
lated strains, respectively.www.sciencedirect.com
Fungi in plant-based supplements and medicines Rocha-Miranda and Venaˆncio 29In a recent study, Su et al. [29] investigated the occur-
rence of fungi in eight root herbs used as medicines,
dietary supplements and functional foods in China and
other countries, and found that all 48 samples tested were
contaminated with fungi (1844 isolates belonging to
25 genera). Aspergillus and Penicillium presented a fre-
quency of 10% and 25%, respectively. The fungal counts
ranged from 12 to 2.5  104/g. Notoginseng and liquorice
were highly contaminated (fungal counts > 103/g); how-
ever, the fungal counts did not exceed the maximum limit
of 105/g set by the WHO. The authors also reported that
among the 13 isolates of A. flavus, five isolates from
Chinese yam, ginseng, astragalus, and liquorice were
found to produce AFB1 and AFB2.
A comprehensive review on the occurrence of mycotoxi-
genic fungi in plant-based products is presented in sup-
plementary Table S1.
Mycotoxin occurrence in plant-based
supplements and medicines
The occurrence of mycotoxins in plant drugs has been
widely published in several countries but Chinese med-
icines are the most studied [30].
Figure 1 presents data on the prevalence of different myco-
toxins in reports published from 2000 [2,11,24,29,31–
37,38,39–55]. The main mycotoxins identified in plant-
based supplements and medicines have been AFs, OTA,
mycoplenolic acid (MPA), STC and trichothecenes.
Discussion and conclusions
The technological advances of synthetic pharmacology in
the last decades overlapped the use of natural medicine
especially in American and European countries. However,
in recent years, there was a progressive increase in the
demand of herbs and preparations of botanical originFigure 1
19%
6%6%
6%
5%
4%
4%
4%
3%
15%
Main mycotoxins detected in plant-based supplements and medicines. Prev
www.sciencedirect.com (dietary supplements or drugs) as alternative or comple-
mentary medicine due to economic, social and cultural
factors [1].
However, the use of natural herbal/plant products also has
its associated risks, and among them fungal contamina-
tion and mycotoxins are public health concerns. Overall,
many studies have shown that fungal contamination in
plant-based supplements and medicinal herbs is quite
frequent. Potential toxigenic species of Aspergillus and
Penicillium have been reported as the most frequent and
dominant ones, but the presence of toxigenic species of
Alternaria and Fusarium may not be overlooked.
A. flavus and A. niger, known producers of aflatoxins and
ochratoxin A, respectively, were often found with high
incidence. In some studies, A. niger group represented
more than 57% of the isolates, followed by A. section
Flavi (50%) [28].
The levels of fungi and mycotoxin contamination found
in plant-based ingredients throws light on the need for
proper care and effective screening before their use.
Thus, it is essential to highlight the need for deeper
knowledge on the presence of fungi and mycotoxins
(including masked forms and emergent metabolites) in
plant-based raw materials widely used as ingredients by
pharmaceutical companies or food industries.
Although there appeared to be a low risk to the consumers
who occasionally use plant-based supplements and
medicinal drugs, it is important to draw special attention
to the potential risk of cumulative effects [56]. The toxic
effects resulting from the co-occurrence of multiple
mycotoxins can be both additive and even synergistic,
that is, the overall toxicity might be higher than the sum
of individual toxicities [57]. These mycotoxin ‘cocktails’
have an underestimated toxicological hazard.13%
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alence of each mycotoxin in the 35 report published since 2000.
Current Opinion in Food Science 2019, 30:27–31
30 Food safetyFinally, the risk of mycotoxin contamination in natural
products, infected or not with fungi, associated with
increased consumption of this type of products, impose
the need of discuss appropriate standards for toxigenic
moulds and mycotoxins in crude herbal drugs, medicinal
plants and plant-based supplements in order to reduce
the risks for consumers.
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